Specialized Site Network For Early-Phase Oncology Success

Purpose-built site network designed for biotech

Catalyst Oncology takes a different approach―offering a purpose-built, multiregional site network designed specifically for early-phase oncology trials. Built on rigorously selected sites with proven oncology expertise, this network thrives on trust-based partnerships that streamline operations and eliminate inefficiencies. By easing the burden on sites, we foster a highly motivated network that consistently meets enrollment targets―accelerating timelines, enhancing data integrity, and delivering meaningful clinical results.

Global, relationship-driven site solutions that deliver

Access to global footprint

• ~20 specialized sites located across the US, Spain, UK and Australia
• 50+ active trials at network sites

Collaborative, relationship-driven approach

• Dedicated relationship managers
• First right of refusal for novel protocols with slot and activation commitments
• Early access to next-gen oncology therapies
• Ongoing, consistent support

Operational efficiency and streamlined start-up

• Master templates, core feasibility, waived SEVs, and site checklists
• Real-time performance feedback and reliable forecasts
• Expedited launch, elimination of inefficiencies, reduced site fatigue

Tailored, data-driven solutions

• Assessments of site capabilities and financial needs
• Customized tech and resourcing strategies

Our site network team

Explore how you can become a strategic site partner

Exclusively biotech-focused

Built to work exclusively with biotechs, our flexible processes and approach allow us to listen first, align goals, and execute with an eye toward rapid shifts when a protocol is amended or Breakthrough designation moves a product straight from Phase I to registration.

Seasoned oncology experts

With an average of 9+ years of oncology experience for key roles (PM, CTL, DM, Bios, Clinical Science), our oncology specialty guarantees you a seasoned team across all functions.

A transparent people-first culture with industry-leading retention

We are responsive and attentive to the needs of both our customers and staff. Our industry-leading employee and project team retention guarantees program continuity, increased efficiency, and happy investigative sites.

Additional differentiators

Catalyst Oncology offers a flexible data-driven approach with an experienced network of sites across a global footprint.

• 91% corporate retention rate
• Flexible solutions and best-in-class technologies
• Data-centric approach with visual analytics and clinical science
• Site network Catalyst Oncology approved and trusted site network
• Global footprint 1000+ staff across US, EU & APAC

Active next-gen oncology experience

Working both locally and globally across Phases I through III in a range of solid tumor and hematologic indications, we understand the nuances of complex study designs, novel endpoints, and cutting-edge technologies.